Using Genetic and Blood Metabolites to Understand the Risk of Alzheimer's Disease in Latinos
Using Genetic and Blood Metabolites to Understand the Risk of Alzheimer's Disease in Latinos
批准号:
10845817
负责人:
Tamar Sofer
金额:
$3.66万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2023-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
U.S. Latinos are highly diverse, with individuals originating from central and south America, as well as the
Caribbean. Latinos are socioeconomically disadvantaged compared to U.S. Whites, and suffer from a higher
prevalence of Alzheimer’s disease and related dementia. Genetic determinants of Alzheimer’s disease may be
somewhat different in Latinos compared to Whites: in preliminary results, we found that genetic background,
in the form of proportion of genome inherited from Amerindian (Native American) ancestors mitigates the
detrimental effect of the APOE-𝜖𝜖4 variants on cognitive decline in individuals from the Hispanic Community
Health Study/Study of Latinos (HCHS/SOL). This suggests heterogeneity in genetically-based mechanisms
underlying neurocognitive decline in Latinos.
Untargeted metabolomics is a promising approach to develop potential biomarkers for human disease. Previous
metabolomics studies identified potential biomarkers for Alzheimer’s disease and for cognitive traits in a cross-
sectional manner, however, very little work was done specifically in Latinos, and the genetics and metabolomics
have not been integrated for risk prediction, apart from using APOE-𝜖𝜖4. Here, we propose to utilize a dataset
including ~1,500 older Latino adults from the HCHS/SOL with untargeted metabolomics measured at a baseline
visit, and neurocognitive function estimated in both the baseline and a follow-up visit. Our goals are: (1) develop
preliminary biomarkers for aging-related cognitive decline phenotypes (e.g. change in global cognitive function,
mild cognitive impairment); (2) study the genetic basis of the association of metabolites with cognitive decline,
and study potential heterogeneity by genetic background; and (3) form recommendations and a grant
application to support a larger research program utilizing genetics and metabolomics, and potentially other
‘omics, to develop biomarkers of Alzheimer’s disease in diverse populations, and study underlying mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using polygenic risk scores and omics to study how suboptimal sleep accelerates cognitive aging in diverse populations
-
批准号:10735647
-
项目类别:
-
资助金额:$95.95万
-
财政年份:2023
-
负责人:Tamar Sofer
-
依托单位:
Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/Latinos
-
批准号:10516256
-
项目类别:
-
资助金额:$73.76万
-
财政年份:2022
-
负责人:Tamar Sofer
-
依托单位:
Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/Latinos
-
批准号:10850324
-
项目类别:
-
资助金额:$66.17万
-
财政年份:2022
-
负责人:Tamar Sofer
-
依托单位:
Using Genetic and Blood Metabolites to Understand the Risk of Alzheimer's Disease in Latinos
-
批准号:10299916
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2021
-
负责人:Tamar Sofer
-
依托单位:
Leveraging Correlated Traits to Identify Genetic Associations with Sleep Disordered Breathing
-
批准号:9814425
-
项目类别:
-
资助金额:$13.43万
-
财政年份:2019
-
负责人:Tamar Sofer
-
依托单位:
海外基金